Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients. 1992

L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City.

OBJECTIVE To define the source of invasive coagulase-negative staphylococci (CNS) and the epidemiology of strain variation in immunocompromised patients. METHODS Weekly microbial surveillance cultures were obtained from the nares, throat, skin, rectum, and urine. Plasmid pattern analysis was performed on all coagulase-negative staphylococci isolated from blood cultures and on selected strains from the surveillance sites. METHODS A 902-bed, university-owned, tertiary-care referral hospital. METHODS Forty-four patients on the bone marrow transplant or hematologic malignancy services. RESULTS Plasmid pattern analysis was performed on 340 surveillance isolates (median = 7 per patient) and 201 bloodstream isolates (median = 3 per patient). Patients were colonized with numerous unique strains (median = 5 per patient) of coagulase-negative staphylococci. The 44 patients had 108 episodes of positive blood cultures, 20 of which were preceded by colonization with the same strain. Isolation of the matching strain from surveillance cultures preceded the positive blood culture by 1 to 8 days in 9 episodes and 18 to 389 days in 11 episodes. The matching strain was isolated from the skin in only 6 (30%) of those episodes and from mucosal sites in 70%. Of the 108 episodes of positive blood cultures, 21 were identified as nosocomial bloodstream infections. Four of the 21 nosocomial bloodstream infections were preceded by colonization with the same strain. In all 4 episodes, the infecting strain was cultured from the nares before the blood cultures were obtained. CONCLUSIONS Our results suggest that mucous membranes might be sources for strains of CNS causing bacteremia.

UI MeSH Term Description Entries
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D003030 Coagulase Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen. Staphylocoagulase,Staphylococcal Clumping Factor,Clumping Factor (Staphylococcal),Staphylococcus aureus clone pSCa2 of Coagulase,Staphylococcus aureus strain 213 of Coagulase,Staphylococcus aureus strain 8325-4 of Coagulase,Clumping Factor, Staphylococcal,Factor, Staphylococcal Clumping,Staphylococcus aureus strain 8325 4 of Coagulase
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D016867 Immunocompromised Host A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation. Immunosuppressed Host,Immunocompromised Patient,Host, Immunocompromised,Host, Immunosuppressed,Hosts, Immunocompromised,Hosts, Immunosuppressed,Immunocompromised Hosts,Immunocompromised Patients,Immunosuppressed Hosts,Patient, Immunocompromised,Patients, Immunocompromised
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
January 1994, Acta microbiologica et immunologica Hungarica,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
September 1986, Immunitat und Infektion,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
November 1987, Antimicrobial agents and chemotherapy,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
February 1982, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
September 2002, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
December 1990, Veterinarni medicina,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
July 1989, Journal of chemotherapy (Florence, Italy),
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
April 2000, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
June 2011, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine,
L A Herwaldt, and R J Hollis, and L D Boyken, and M A Pfaller
September 1998, The Journal of dermatology,
Copied contents to your clipboard!